Cargando…
Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study
BACKGROUND: In February 2011, an Ohio law took effect mandating use of the United States Food and Drug Administration (FDA)-approved protocol for mifepristone, which is used with misoprostol for medication abortion. Other state legislatures have passed or enacted similar laws requiring use of the FD...
Autores principales: | Upadhyay, Ushma D., Johns, Nicole E., Combellick, Sarah L., Kohn, Julia E., Keder, Lisa M., Roberts, Sarah C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004901/ https://www.ncbi.nlm.nih.gov/pubmed/27575488 http://dx.doi.org/10.1371/journal.pmed.1002110 |
Ejemplares similares
-
Sociodemographic Characteristics of Women Able to Obtain Medication Abortion Before and After Ohio's Law Requiring Use of the Food and Drug Administration Protocol
por: Upadhyay, Ushma D., et al.
Publicado: (2018) -
Evaluating the impact of a mandatory pre-abortion ultrasound viewing law: A mixed methods study
por: Upadhyay, Ushma D., et al.
Publicado: (2017) -
Estimating the proportion of Medicaid-eligible pregnant women in Louisiana who do not get abortions when Medicaid does not cover abortion
por: Roberts, Sarah C. M., et al.
Publicado: (2019) -
Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19()
por: Upadhyay, Ushma D., et al.
Publicado: (2020) -
Distance traveled for Medicaid-covered abortion care in California
por: Johns, Nicole E., et al.
Publicado: (2017)